A comparison of Isopaque Coronar 370 and Amipaque in angiocardiography in infants.
Experimental studies and some clinical investigations have indicated that Amipaque (metrizamide) is less cardiotoxic than other contrast media in common use for angiocardiography. It, therefore, seemed motivated to find out whether these findings are valid in the high-risk group of neonates and small infants subjected to angiocardiography.
D000790:Angiocardiography; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004338:Drug Combinations; D006330:Heart Defects, Congenital / Q000000981:diagnostic imaging; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007463:Iodobenzoates; D008536:Meglumine / Q000031:analogs & derivatives; D008793:Metrizamide / Q000009:adverse effects; D008794:Metrizoic Acid / Q000009:adverse effects / Q000031:analogs & derivatives
D004338:Drug Combinations; D007463:Iodobenzoates; D008536:Meglumine; D008794:Metrizoic Acid; D008793:Metrizamide; C021342:methylglucamine metrizoate